JUL 21, 2016 4:31 AM PDT

Liquid Aspirin Could Be The Silver Bullet For Brain Tumors

In the field of neuroscience, and specifically research, the greatest need is arguably in the area of brain tumors. One of the most aggressive forms of brain cancer is glioblastoma multiforme. There is no known treatment for these tumors because the drugs that could kill them cannot get past the blood-brain barrier. Designed to keep toxic substances away from the brain, it works a little too well in that cancer drugs, many of which are toxic in one way but helpful in others, cannot get to the site of these aggressive tumors. A new potential breakthrough from a research team in the UK could offer some hope to brain tumor patients however.

A soluble liquid aspirin can get past the blood brain barrier

Prof. Geoff Pilkington and Dr. Richard Hill, from the Brain Tumour Research Centre of Excellence at the University of Portsmouth, England presented their research findings late last month at a brain tumor conference in Poland and their findings have the neuroscience community talking about possibly the first real drug that could actually reach the brain. 

Their group has been collaborating with a privately held drug company in the UK, Innovate Pharmaceuticals. Together the Brain Tumour Centre research team, Innovate developed a formulation they refer to as IP1867B. It contains a liquid reformulation of aspirin and two other ingredients and is in soluble form. The development of stable soluble liquid aspirin has been the goal of many companies and researchers. Despite many attempts, up until now there have not been any successful efforts. Every try has resulted in a formulation that still contains tiny grains of the active ingredient salicylic acid, and it’s these particles that cause gastric distress and keep the liquid from being able to pass through the blood brain barrier

The ability of IP1867B to slip through the miniscule openings in the blood brain barrier is what makes this discovery significant for patients with brain tumors. Glioblastoma is the deadliest known form of brain cancer, striking almost 200,000 people per year in the United States alone. These tumors are extremely aggressive and there is no cure. The prognosis for patients with glioblastoma is in terms of median survival, with almost 90% of patients dying from the disease within five years.

The team of researchers in the UK worked with cancer cells from adults and children with brain tumors. Cells from a variety of tumors were exposed to IP1867B alone and in combination with one or both of the other two ingredients. Results from these experiments showed that it was ten times more effective against cancer cells than any other treatment including chemotherapy agents and radiation alone and in combination.

Even more significant than the effect on the cancer cells is that none of the three ingredients in the formulation was harmful to surrounding normal cells. While the results of this trial are certainly exciting for researchers and patients alike, more research is needed to develop it into pre-clinical form and further on to develop clinical trials with patients and not just cell samples. In a press release, Sue Farrington Smith, Chief Executive of Brain Tumour Research, said, “This is a potential game-changer for research into brain tumours and clearly shows what sustainable research is able to achieve.  It is science like this that will enable us to eventually find a cure for this devastating disease which kills more children and adults under the age of 40 than any other cancer.” Check out the video below to learn more.


Sources: University of Portsmouth, American Brain Tumor Asssociation, iTechPost
 

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
APR 14, 2021
Cell & Molecular Biology
Repairing Traumatic Brain Injuries with 'Brain Glue'
APR 14, 2021
Repairing Traumatic Brain Injuries with 'Brain Glue'
Brain injuries are common, costly, and difficult to treat. The brain damage that accompanies a significant traumatic bra ...
APR 22, 2021
Cannabis Sciences
Cannabis Use Disorder in Pregnancy Linked to Infant Health Problems
APR 22, 2021
Cannabis Use Disorder in Pregnancy Linked to Infant Health Problems
Researchers have found that babies born to mothers diagnosed with cannabis use disorders at delivery are more likely to ...
MAY 06, 2021
Drug Discovery & Development
Are Hallucinations Necessary for Psychedelics to Treat Depression?
MAY 06, 2021
Are Hallucinations Necessary for Psychedelics to Treat Depression?
Many who work with psychedelics say that hallucinations, or psychedelic experiences, are an integral part of psychedelic ...
MAY 20, 2021
Cannabis Sciences
Cannabis Improves Symptoms in Over Half of Patients with Parkinson's Disease
MAY 20, 2021
Cannabis Improves Symptoms in Over Half of Patients with Parkinson's Disease
Researchers from the University Medical Center Hamburg-Eppendorf in Germany have found that cannabis products may produc ...
MAY 23, 2021
Neuroscience
Depressed People Have Different Levels of Lithium in Their Brains
MAY 23, 2021
Depressed People Have Different Levels of Lithium in Their Brains
Researchers at the Technical University of Munich have found that lithium is distributed differently in the brains of pe ...
MAY 27, 2021
Technology
High Amounts of TV Watching for Middle-aged Adults Could Cause Cognitive Decline
MAY 27, 2021
High Amounts of TV Watching for Middle-aged Adults Could Cause Cognitive Decline
How often do you watch T.V. each week? Each day? It turns out, the amount of T.V. you watch as a middle-aged adult could ...
Loading Comments...